# A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China

> **NCT06701149** · PHASE1 · COMPLETED · sponsor: **Simcere Pharmaceutical Co., Ltd** · enrollment: 178 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** Rademikibart injection
- **DRUG:** CBP-201 injection

## Key facts

- **NCT ID:** NCT06701149
- **Lead sponsor:** Simcere Pharmaceutical Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-28
- **Primary completion:** 2025-05-22
- **Final completion:** 2025-05-22
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701149, "A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06701149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*